Nomura Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-25,131
| Closed | -$6.17M | – | 1791 |
|
2022
Q3 | $6.17M | Sell |
25,131
-133
| -0.5% | -$32.7K | 0.04% | 394 |
|
2022
Q2 | $6.25M | Buy |
25,264
+15,360
| +155% | +$3.8M | 0.04% | 397 |
|
2022
Q1 | $3.28M | Sell |
9,904
-10,710
| -52% | -$3.55M | 0.02% | 610 |
|
2021
Q4 | $7.4M | Buy |
20,614
+11,516
| +127% | +$4.14M | 0.04% | 393 |
|
2021
Q3 | $2.96M | Sell |
9,098
-90
| -1% | -$29.3K | 0.02% | 616 |
|
2021
Q2 | $2.87M | Buy |
9,188
+1,091
| +13% | +$341K | 0.02% | 637 |
|
2021
Q1 | $2.58M | Buy |
8,097
+301
| +4% | +$95.9K | 0.02% | 636 |
|
2020
Q4 | $2.53M | Buy |
7,796
+9
| +0.1% | +$2.92K | 0.02% | 624 |
|
2020
Q3 | $2.16M | Buy |
7,787
+12
| +0.2% | +$3.32K | 0.02% | 595 |
|
2020
Q2 | $1.88M | Sell |
7,775
-50
| -0.6% | -$12.1K | 0.02% | 607 |
|
2020
Q1 | $1.14M | Buy |
7,825
+854
| +12% | +$124K | 0.01% | 667 |
|
2019
Q4 | $1.19M | Sell |
6,971
-20
| -0.3% | -$3.41K | 0.01% | 759 |
|
2019
Q3 | $1.24M | Buy |
6,991
+33
| +0.5% | +$5.87K | 0.01% | 729 |
|
2019
Q2 | $1.81M | Buy |
6,958
+486
| +8% | +$127K | 0.02% | 616 |
|
2019
Q1 | $1.85M | Buy |
6,472
+24
| +0.4% | +$6.85K | 0.02% | 593 |
|
2018
Q4 | $2.1M | Buy |
6,448
+740
| +13% | +$241K | 0.02% | 489 |
|
2018
Q3 | $2.57M | Buy |
5,708
+122
| +2% | +$54.9K | 0.02% | 474 |
|
2018
Q2 | $2.29M | Buy |
+5,586
| New | +$2.29M | 0.02% | 507 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 1050 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 1043 |
|